Meeder Asset Management Inc. Sells 34,117 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Meeder Asset Management Inc. cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 98.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 406 shares of the company’s stock after selling 34,117 shares during the quarter. Meeder Asset Management Inc.’s holdings in HCA Healthcare were worth $122,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Physician Wealth Advisors Inc. bought a new stake in shares of HCA Healthcare in the fourth quarter worth about $64,000. CIBC Private Wealth Group LLC raised its holdings in HCA Healthcare by 0.6% during the 4th quarter. CIBC Private Wealth Group LLC now owns 20,059 shares of the company’s stock worth $6,243,000 after buying an additional 120 shares during the period. California Public Employees Retirement System increased its position in shares of HCA Healthcare by 2.6% during the fourth quarter. California Public Employees Retirement System now owns 353,702 shares of the company’s stock worth $106,164,000 after acquiring an additional 9,015 shares in the last quarter. RWA Wealth Partners LLC lifted its position in HCA Healthcare by 8.7% in the 4th quarter. RWA Wealth Partners LLC now owns 1,867 shares of the company’s stock valued at $560,000 after acquiring an additional 149 shares in the last quarter. Finally, Allianz SE acquired a new stake in shares of HCA Healthcare in the 4th quarter valued at about $1,009,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA opened at $345.86 on Wednesday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The business has a fifty day simple moving average of $325.79 and a 200 day simple moving average of $340.25. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a market capitalization of $85.15 billion, a PE ratio of 15.74, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the firm earned $5.90 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Analyst Ratings Changes

HCA has been the subject of a number of research reports. Bank of America decreased their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. Royal Bank of Canada reduced their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. Truist Financial cut their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. KeyCorp dropped their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.